PTC Therapeutics, Inc.
(NASDAQ : PTCT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
-0.15%46.308.1%$691.09m
AMGNAmgen Inc.
0.23%177.871.3%$498.24m
CELGCelgene Corporation
-0.28%91.281.3%$433.22m
GILDGilead Sciences, Inc.
-0.07%66.900.9%$401.77m
BIIBBiogen Inc.
-0.82%229.661.3%$372.44m
ILMNIllumina, Inc.
0.07%302.513.5%$354.41m
REGNRegeneron Pharmaceuticals, Inc.
-0.05%298.222.6%$267.23m
ALXNAlexion Pharmaceuticals, Inc.
0.37%123.282.0%$197.74m
SRPTSarepta Therapeutics, Inc.
0.40%153.8614.7%$197.07m
VRTXVertex Pharmaceuticals Incorporated
0.38%176.831.9%$181.40m
AAgilent Technologies, Inc.
0.00%69.951.6%$140.82m
EXASExact Sciences Corporation
0.39%115.4024.1%$136.84m
INCYIncyte Corporation
-0.55%79.442.5%$109.26m
BLUEBluebird Bio, Inc.
0.97%134.9614.3%$94.72m
BMRNBioMarin Pharmaceutical Inc.
-1.13%81.444.3%$83.37m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.